Sanlayan, Klea .
HRN: 19-83-45 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
MUPIROCIN 2%, 15G (TUBE)
12/29/2022
01/04/2023
TOPICAL
Small Amount
TID
T/c Skin Infection
Waiting Final Action
Indication: Prophylaxis Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes